A 3‐year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion

@article{Novelli2003A3E,
  title={A 3‐year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion},
  author={Gilnardo Novelli and Massimo Rossi and Renzo Pretagostini and Luigi Novelli and Luca Poli and Giancarlo Ferretti and Massimo Iappelli and Pasquale Bartolomeo Berloco and Raffaello Cortesini},
  journal={Liver International},
  year={2003},
  volume={23}
}
Abstract In our 3‐year experience, we treated 63 patients with Molecular Adsorbent Recirculating System (MARS). The patients were divided as follows: 10 primary non‐function (PNF) 16%, 10 delayed non‐function (DNF) 16%, 16 Fulminant hepatitis (FH) 24%, 23 acute decompensation of chronic liver disease (ACLF) 38%, and 4 hepatic resection 6%. All patients who underwent MARS treatment had bilirubin >15 mg/dL, Glasgow Coma Score between 9 and 11, ammonium >160 µg/dL and non‐coagulability. The… 
Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation
TLDR
A statistically significant improvement of liver function was observed after MARS therapy, andTransplant-free recovery was more frequent than expected and the apparent benefit of MARS dialysis to treat acute liver failure needs to be confirmed by a controlled study.
Liver Transplantation Avoided in Patients With Fulminant Hepatic Failure Who Received Albumin Dialysis With the Molecular Adsorbent Recirculating System While on the Waiting List: Impact of the Duration of Therapy
  • C. Camus, S. Lavoué, +5 authors Y. le Tulzo
  • Medicine
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
  • 2009
TLDR
It is suggested that MARS therapy could contribute to native liver recovery and is safe in patients on the waiting list for fulminant hepatic failure and a minimum duration of therapy (≥15 h) could be necessary to expect significant liver function improvement.
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis
TLDR
The use of ECAD may be associated with an earlier and more frequent improvement of HE (grade 3/4) and a full assessment of the role of albumin dialysis awaits the results of additional controlled trials.
Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure*
  • H. Ringe, V. Varnholt, +7 authors U. Querfeld
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2011
TLDR
In childhood acute liver failure, treatment with single-pass albumin dialysis was generally well tolerated and seems to be effective in detoxification and in improving blood pressure, thus stabilizing the critical condition of children before liver transplantation and facilitating bridging to liver transplation.
Liver support for fulminant hepatic failure: Is it time to use the Molecular Adsorbents Recycling System in children?*
  • P. Tissières, J. Sasbón, D. Devictor
  • Medicine
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  • 2005
TLDR
Although promising preliminary results suggest that MARS may have a significant position in the therapeutic arsenal for FHF, no sufficient data exist to justify its use in children, and the indications of this expensive technique in children with FHF are limited.
Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure
TLDR
Despite the lack of large multicentre randomized trials on the use of MARS™ in patients with acute liver failure, the literature shows clinical and biological benefit from this technique, and it is potentially a promising treatment for Patients with acute poisoning from drugs that have high protein-binding capacity and are metabolized by the liver.
Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute‐on‐chronic liver failure patients
TLDR
Potential mechanisms of HE in ACLF indicating that ammonia and abnormal cerebral oxygenation are important are described, and results suggest that ammonia, JVO2, and WCC are important prognostic biomarkers and therapeutic targets.
578 Seven Day Anhepatic Survival in a 19 Month Old Child, an Interdisciplinary Challenge
TLDR
Overall 16 surgical interventions including increased intra-abdominal pressure, portal vein kinking, portal and arterial thrombosis (second graft), removal of mesenterial lymphoid cysts, bile-duct-leak, second re-transplantation with cavo-portal anastomosis, and secondary abdominal wall closure with dermal-porcine-collagen, skin-mesh-grafts were needed to save the boy.
Temporary Liver Support : Current Concepts
463 Liver failure occurs either as acute liver failure (ALF) developing de novo or as acute decompensation of chronic liver disease (ACLF). The clinical manifestations are fairly similar
Extracorporeal renal and liver support in pediatric acute liver failure
TLDR
There is a lack of standardization of indications for ECLAD, availability of different extracorporeal devices with varied technical approaches, and, of note, the differences in doses of ECLad provided in clinical practice.
...
1
2
3
4
...

References

SHOWING 1-10 OF 19 REFERENCES
Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure
TLDR
Cerebral perfusion is increased and levels of ammonia and bilirubin are reduced during MARS treatment in patients with AOCLF.
Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute‐on‐chronic liver failure
TLDR
In conclusion, MARS treatment proved safe in critically ill patients with no attributing side effects and systemic hemodynamic variables were determined before and during treatment.
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
As reported in the literature, the mortality rates for patients with Acute Hepatic Failure (AHF) approaches 80% in cases in which liver transplantation is not possible. Post-transplant mortality
Acute liver failure: results of a 5-year clinical protocol.
  • M. Daas, D. Plevak, +5 authors J. Steers
  • Medicine
    Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 1995
TLDR
Outcome is improved if transplantation occurs before grade IV encephalopathy, and ICP monitoring can be accomplished without significant risk of hemorrhage, in patients with acute liver failure.
Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.
TLDR
A new membrane separation system that is nearly impermeable to proteins but enables the exchange of water soluble and protein bound toxins by a special membrane and a recycled protein containing dialysate is described.
The value of serial Doppler ultrasound as a predictor of clinical outcome and the need for transplantation in fulminant and severe acute liver failure.
TLDR
The mean HARI is significantly higher in patients who fulfil transplant criteria and may possibly be used as an indicator of poorer prognosis and the need for liver transplantation in acute severe and fulminant liver failure.
Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria.
TLDR
Two sets of prognostic indicators were recently proposed for selection of patients with acute liver failure for emergency liver transplantation and the positive predictive values were equal to 1 for the two sets, but the predictive accuracies only slightly increased.
Characteristics of an Albumin Dialysate Hemodiafiltration System for the Clearance of Unconjugated Bilirubin
TLDR
The clearance of unconjugated bilirubin is greatly enhanced with the use of albumin containing dialysates when compared to traditional crystalloid hemodiafiltration, is greater at lower pH, and seems to be unaffected by temperature.
Extracorporeal blood purification in the management of patients with hepatic failure.
TLDR
A review of the rationale and documented utility of a wide variety of blood purification modalities used in the management of patients with liver failure finds them to be helpful in maintaining fluid, electrolyte, and acid base balance.
The pathophysiological basis of acute-on-chronic liver failure.
TLDR
This review focuses upon how a precipitant such as an episode of gastrointestinal bleeding or sepsis may start a cascade of events that culminate in end-organ dysfunction and liver failure.
...
1
2
...